Application

PTO- 1478

Approved for use through 09/30/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 09/30/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97044610

Filing Date: 09/24/2021

To the Commissioner for Trademarks:

MARK: VOYAGER (stylized and/or with design, see mark)
The literal element of the mark consists of VOYAGER. The applicant is not claiming color as a feature of the mark. The mark consists of the word VOYAGER. The letter "O" is replaced with a design comprising three concentric circles with two circles placed to the upper right and lower left of the concentric circles.
The applicant, Voyager Therapeutics, Inc., a corporation of Delaware, having an address of
      75 Sidney Street
      Cambridge, Massachusetts 02139
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Biological preparations for gene therapy; adeno-associated virus (AAV) gene therapy; Biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, treatment of disease, namely, neurological diseases; treatments for neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; polypeptides for gene therapy; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; Drug delivery agents consisting of capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Pharmaceutical research and development in the field of gene therapy; Pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research, development, and collaboration services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of RNA-based functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical services provided for clinical trials; Providing patient care for clinical trials; Providing medical and scientific research information in the field of clinical trials and gene therapy; Providing a website featuring medical information and medical research
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The owner's/holder's proposed attorney information: Keith Toms, Esq.. Other appointed attorneys are Aya Cieslak-Tochigi, Esq., Jin Wang, Esq., Alexander Ried, Esq.. Keith Toms, Esq., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      265 Franklin Street
      Boston, Massachusetts 02110-3113
      United States
      617-449-6500(phone)
      ktoms@mccarter.com
The docket/reference number is 135333-90901.
Keith Toms, Esq. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Keith Toms, Esq.

PRIMARY EMAIL FOR CORRESPONDENCE: ktoms@mccarter.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): bostontrademarks@mccarter.com; acieslaktochigi@mccarter.com; mandrews@mccarter.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Diana Collazo/   Date: 09/24/2021
Signatory's Name: Diana Collazo
Signatory's Position: Chief Patent Counsel
Signatory's Phone Number: 000-000-0000
Signature method: Sent to third party for signature
Payment Sale Number: 97044610
Payment Accounting Date: 09/24/2021

Serial Number: 97044610
Internet Transmission Date: Fri Sep 24 18:18:57 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.XX.XX-202109241818571891
00-97044610-781ec6c8cf89129a20cf32118e82
b09932a87a5847815c77e242946b88115c5082-D
A-18560277-20210924161059512022